Clinical Trial Update: Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts [NA]

View source ↗

Summary

Clinical trial investigated fluoxetine to reduce cocaine use in individuals with cocaine- and opioid-use disorders; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders
• Opioid-related Disorders

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders, Opioid-Related Disorders | NA | Status: COMPLETED